Health
Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in lab setting – Medical Xpress
Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that…
Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat…
Continue Reading
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News20 hours agoBrisbane news live: Broken-down train causes peak-hour delays